We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLY icon
351
John Wiley & Sons Class A
WLY
$2.76B
– –
-444
Closed -$14K
WYNN icon
352
Wynn Resorts
WYNN
$10.3B
– –
-3,603
Closed -$259K
MAGN
353
Magnera Corp
MAGN
$498M
– –
-65
Closed -$12K
PRSU
354
Pursuit Attractions and Hospitality Inc
PRSU
$1.48B
– –
-445
Closed -$9K
BERY
355
DELISTED
Berry Global Group, Inc.
BERY
– –
-9,362
Closed -$415K
AJRD
356
DELISTED
Aerojet Rocketdyne Holdings
AJRD
– –
-436,992
Closed -$17.4M
SUMO
357
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
– –
-113,853
Closed -$2.48M
DCT
358
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
– –
-350
Closed -$16K
IVC
359
DELISTED
Invacare Corporation
IVC
– –
-8,500
Closed -$64K
ADMS
360
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-642,226
Closed -$2.65M
STAY
361
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-1,441
Closed -$17K
CUB
362
DELISTED
Cubic Corporation
CUB
– –
-440
Closed -$26K
PS
363
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
– –
-1,408,142
Closed -$24.1M
BSTC
364
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-900
Closed -$48K
BEAT
365
DELISTED
BioTelemetry, Inc.
BEAT
– –
-4,094
Closed -$187K
QTWW
366
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
$0 ﹤0.01%
15
– –
EBIX
367
DELISTED
Ebix Inc
EBIX
– –
-649
Closed -$13K
AAWW
368
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
– –
-354
Closed -$22K
BDSI
369
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-1,655,711
Closed -$6.18M
AAN.A
370
DELISTED
The Aaron's Company Inc Class A
AAN.A
– –
-397
Closed -$22K
11 12 13 14
15

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.